tiprankstipranks
Advertisement
Advertisement

SNY Stock Latest News

Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials
Market NewsNovartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials
2d ago
NVS
SNY
Sanofi: Balanced Risk-Reward as Pipeline Setbacks and Dupixent LOE Temper Growth Outlook, With BD/M&A Execution Key to Equity Story
PremiumRatings
Sanofi: Balanced Risk-Reward as Pipeline Setbacks and Dupixent LOE Temper Growth Outlook, With BD/M&A Execution Key to Equity Story
3d ago
SNY
Sanofi Extends Lunsekimig COPD Program With Long-Term Safety Study
PremiumCompany Announcements
Sanofi Extends Lunsekimig COPD Program With Long-Term Safety Study
6d ago
SNY
Novavax’s partners approved for Nuvaxovid formulation for vaccination season
PremiumThe Fly
Novavax’s partners approved for Nuvaxovid formulation for vaccination season
6d ago
SNY
TAK
Sanofi and Blueprint Advance First-in-Human Pan-KRAS Cancer Trial, Eyeing New Oncology Upside
PremiumCompany Announcements
Sanofi and Blueprint Advance First-in-Human Pan-KRAS Cancer Trial, Eyeing New Oncology Upside
10d ago
SNY
Sanofi’s New H5N8 Flu Vaccine Trial Signals Long-Term Pandemic Preparedness Play
PremiumCompany AnnouncementsSanofi’s New H5N8 Flu Vaccine Trial Signals Long-Term Pandemic Preparedness Play
13d ago
SNY
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
Premium
The Fly
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
23d ago
SNY
Midday Fly By: Intel announces $15B offering, Meta unveils Muse Glimmer
Premium
The Fly
Midday Fly By: Intel announces $15B offering, Meta unveils Muse Glimmer
24d ago
BA
ACH
Sanofi facing shortages of two drugs for Pompe disease, STAT reports
PremiumThe Fly
Sanofi facing shortages of two drugs for Pompe disease, STAT reports
24d ago
SNY
Sanofi Wins EU Approval to Use MenQuadfi in Infants From Six Weeks
PremiumCompany Announcements
Sanofi Wins EU Approval to Use MenQuadfi in Infants From Six Weeks
28d ago
6K
SNY
Regeneron and Sanofi Terminate Real‑World Dupilumab Study in Chronic Urticaria
PremiumCompany Announcements
Regeneron and Sanofi Terminate Real‑World Dupilumab Study in Chronic Urticaria
1M ago
SNY
REGN
Regeneron price target raised to $737 from $696 at RBC Capital
PremiumThe Fly
Regeneron price target raised to $737 from $696 at RBC Capital
1M ago
SNY
REGN
Morning Movers: Baxter surges following beat and raise report
PremiumThe FlyMorning Movers: Baxter surges following beat and raise report
1M ago
MO
BAX
Sanofi expects FY26 sales to grow by around 10% at CER
Premium
The Fly
Sanofi expects FY26 sales to grow by around 10% at CER
1M ago
SNY
Sanofi reports Q2 business EPS EUR 2.09, up 31.4% reported
Premium
The Fly
Sanofi reports Q2 business EPS EUR 2.09, up 31.4% reported
1M ago
SNY
Sanofi’s MenQuadfi Safety Study in Korea: What Investors Should Watch
PremiumCompany Announcements
Sanofi’s MenQuadfi Safety Study in Korea: What Investors Should Watch
1M ago
SNY
Sanofi Targets Dual RSV–HMPV Opportunity With Fresh Phase 1/2 Vaccine Study
PremiumCompany Announcements
Sanofi Targets Dual RSV–HMPV Opportunity With Fresh Phase 1/2 Vaccine Study
1M ago
SNY
Sanofi Pauses Key Bronchiectasis Trial, Raising Questions For SNY Investors
PremiumCompany Announcements
Sanofi Pauses Key Bronchiectasis Trial, Raising Questions For SNY Investors
1M ago
SNY
SNY Earnings this Week: How Will it Perform?
PremiumPre-Earnings
SNY Earnings this Week: How Will it Perform?
1M ago
SNY
Sanofi Reshapes Executive Committee for Next Strategic Chapter
PremiumCompany AnnouncementsSanofi Reshapes Executive Committee for Next Strategic Chapter
1M ago
6K
SNY
Sanofi Advances Real-World Asthma Study, Sharpening Its Long-Term Biologics Strategy
Premium
Company Announcements
Sanofi Advances Real-World Asthma Study, Sharpening Its Long-Term Biologics Strategy
1M ago
SNY
Sanofi Targets New Growth With Bioequivalence Study for REZUROCK Suspension
Premium
Company Announcements
Sanofi Targets New Growth With Bioequivalence Study for REZUROCK Suspension
1M ago
SNY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >